Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.

Journal of hypertension - 1 Aug 2010

Testa Alessandra, Mallamaci Francesca, Macrì Roberta, Pisano Anna, Spoto Belinda, Malatino Lorenzo S, Stancanelli Benedetta, Tripepi Giovanni, Benedetto Francesco A, Zoccali Carmine

Abstract excerpt

BACKGROUND: Neuropeptide Y (NPY) is a sympathetic neurotransmitter that acts on multiple receptors involved in cardiovascular remodelling and angiogenesis. Plasma levels of NPY are increased in patients with end-stage renal disease (ESRD) and are independently related to left ventricular hypertrophy (LVH) and incident cardiovascular events in these patients. OBJECTIVE: To investigate the relationship between NPY...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comorbidity
Share to Hypertrophy, Left Ventricular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Logistic Models

Share to Neuropeptide Y

Share to Receptors, Neuropeptide Y

Share to Renal Dialysis

Source

Identifiers

PMID: 20543711
DOI: 10.1097/HJH.0b013e32833bd21b

Genes

NPY

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.PMID 20543711Read ↗

Neuropeptide Y gene polymorphisms and chronic kidney disease progression.Semantic proximity Read ↗

Variation at the beta-1 adrenoceptor gene locus affects left ventricular mass in renal failure.Semantic proximity Read ↗

Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling.Semantic proximity Read ↗

Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease.Semantic proximity Read ↗

Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.Semantic proximity Read ↗

Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathySemantic proximity Read ↗

No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.Semantic proximity Read ↗

Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease.Semantic proximity Read ↗

Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.